We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended July 26.
These companies are all new to coverage during the past two months--plus, they earn narrow or wide Morningstar Economic Moat Ratings.
These undervalued wide- and narrow-moat names were recently added to the Morningstar Global ex-US Moat Focus Index.
These wide-moat firms all earn Exemplary stewardship ratings and trade in 4- and 5-star range.
These quality stocks have been added to the Morningstar Dividend Yield Index.
These stocks all experienced significant fair-value increases in June--and one enjoyed a moat boost, too.
Here are our analysts' top ideas in each sector as of midyear.
These stocks carry sky-high price/earnings ratios, but we think they're actually undervalued.
We review the changes to the Morningstar Wide Moat Focus Index during the latest reconstitution and reveal the least-expensive names.
These no-moat names are all up twice as much as the market this year, yet are trading in 4- and 5-star range.
These stocks are trading in 5-star range but carry very high uncertainty.
These wide- and narrow-moat stocks are up more than twice as much as the market this year, yet remain undervalued by our metrics.
These stocks are all extremely overvalued by our standards--and carry high uncertainty ratings, too.
One stock graduated to narrow-moat status last month, while three others enjoyed fair value increases of 20% or more.
These names are among the most expensive in our coverage universe.
These high-quality names are resilient and undervalued.
Want to effectively stabilize your equity exposure? Take a look at funds in these Morningstar Categories.
These high-quality names are trading at 5-star levels.
These names all earn narrow or wide Morningstar Economic Moat Ratings and trade below our fair value estimates.
These companies new to our coverage list all earn economic moat ratings of narrow or better.
Raise a glass: Morningstar turns 35 today. Let's celebrate with some of our favorite mutual fund, ETF, and stock ideas.
T. Rowe Price's David Giroux and Wellington Management's Jean Hynes talk value investing, innovation in healthcare, and where they're finding opportunity.
These wide-moat, low-uncertainty names are reliable.
AQR's Cliff Asness digs into why some multifactor quantitative strategies have been struggling.
Managers from Oakmark, Diamond Hill, and BBH have taken new positions in a beer business, a telecom, and one of the world’s largest consumer product companies.
One stock achieved wide-moat status last month, while three others earned narrow moat ratings.
Here's Morningstar's take on the behemoth's common stock holdings.
Plus, the 10 cheapest names in the index today.
These are the most undervalued stocks we cover with positive moat trends.
A dozen names in the sector earn positive moat trends—and two of the bunch are on sale.
We also upgraded two stocks to narrow-moat status last month. And the icing on the cake: Most of these names are undervalued by our metrics.
Here are some of our analysts' best ideas across sectors.
We’ve cut our fair value estimates on these stocks by more than 10%, but we still like the fundamentals of these companies--at the right price.
These Gold-rated intermediate-term bond funds can provide ballast to a portfolio no matter your life stage.
In a nod to March Madness, here’s our list of elite stocks--and they’re on sale, too.
We expect these high-yielders to sustain their dividends in the future. Plus, they’re cheap.
These narrow- and wide-moat names are beating the market this year yet remain undervalued according to our metrics.
These Gold-rated mutual funds and ETFs provide exposure to the strongest-performing part of the equity market this year.
These wide-moat, low uncertainty names may be slightly overpriced today, but they should be on quality seekers’ watchlists.
These wide- and narrow-moat international stocks are trading well below our fair value estimates.
We like these short- and intermediate-term bond funds as a place to stash your money for the near future.
These stocks enjoyed fair value increases in February. But are they worth buying today?
These names stand to significantly benefit from transformative technologies.
In his annual letter to Berkshire Hathaway shareholders, Warren Buffett argues why the whole is much greater than the sum of its parts--and comments on that sizable cash stake.
These companies may have what it takes to thrive in the future.
These stocks are among the top-10 holdings in several of our favorite dividend-growth funds.
Learn what brought about these Morningstar Analyst Ratings changes.
These undervalued names may not have moats today, but they're maintaining or growing their competitive positions.
These Morningstar Medalists from domestic- and foreign-equity fund categories have started accepting new money.
Several cases can be made for buying what seem to be fairly valued high-quality stocks.